Mukul Mehta has been appointed as the Chief Financial Officer of Novartis, effective March 16, 2026, replacing Harry Kirsch, who will retire after 22 years with the company. Mukul brings over 20 years of experience at Novartis and a strong financial background. Harry Kirsch, the outgoing CFO, has been praised for his significant impact on the company’s growth and transformation during his tenure. Novartis CEO, Vas Narasimhan, commended Harry’s contributions and expressed confidence in Mukul’s ability to lead the company’s financial strategy going forward. Mukul holds a degree in Management and an MBA from top institutions.

Read more at GlobeNewswire: Novartis Appoints Mukul Mehta as Chief Financial Officer,